Precigen Inc (NASDAQ:PGEN)’s traded shares stood at 1.81 million during the last session, with the company’s beta value hitting 1.57. At the close of trading, the stock’s price was $1.75, to imply a decrease of -3.31% or -$0.06 in intraday trading. The PGEN share’s 52-week high remains $2.17, putting it -24.0% down since that peak but still an impressive 62.86% since price per share fell to its 52-week low of $0.65.
Analysts have given a consensus recommendation of Buy for Precigen Inc (PGEN), translating to a mean rating of 1.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give PGEN a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.05.
Precigen Inc (NASDAQ:PGEN) trade information
After registering a -3.31% downside in the last session, Precigen Inc (PGEN) has traded red over the past five days. The 5-day price performance for the stock is -11.17%, and 37.80% over 30 days. With these gigs, the year-to-date price performance is 56.25%.
The extremes give us $6 and $6 for target low and target high price respectively. As such, PGEN has been trading -242.86% off suggested target high and -242.86% from its likely low.
Precigen Inc (PGEN) estimates and forecasts
The rating firms project that company’s revenue will shrink -34.85% compared to the previous financial year.
Revenue forecast for the current quarter as set by 4 analysts is 1.35M. Meanwhile, for the current quarter, a total of 3 analyst(s) estimate revenue growth to 733.33k.Earnings reports from the last fiscal year show that sales brought in 1.23M and 1.06M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 9.93% before dropping -31.14% in the following quarter.
PGEN Dividends
Precigen Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is BLACKROCK INC. with 10.25 million shares, or about 4.1116% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $16.19 million.
We also have Trust for Advised Port-Patient Opportunity Trust and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Precigen Inc (PGEN) shares. Going by data provided on Dec 31, 2024 , Trust for Advised Port-Patient Opportunity Trust holds roughly 14.4 shares. This is just over 4.92% of the total shares, with a market valuation of $25.2 million. Data from the same date shows that the other fund manager holds a little less at 5.45, or 1.86% of the shares, all valued at about 9.54 million.
